Featuring CEO Interview with Dr. Warren Cooper, President, Coalescence Inc.
Volume 2, Number 4
Whether you are or you require executive or management talent — interim, permanent, or interim to hire — Ashton Tweed can meet your specialized retained search and executive search needs.
CEO Leadership Series: Warren Cooper
Check out our latest CEO Interview with Dr. Warren Cooper in its new location! Mr. Cooper draws on decades of experience as a CEO to discuss the importance of building a strong board of directors.
Interim VP of Clinical Development a Permanent Success
A privately held biotechnology company located in New Jersey needed to hire a new Vice President of Clinical Development. The company decided that finding a replacement whose skills would uniquely apply to their technology would be best handled by a professional retained search firm…
3 Ways Interim Talent Can Turn Into A Permanent Asset
Interim talent can be brought on board under many different circumstances. Progress and change are a natural part of the life sciences industry, and that applies to life science staff as well. The ups and downs of business require different talent to be utilized at different times in the process.
Go beyond the news… Get more focused information about your industry and hiring trends. Click now to enhance your subscription.
What’s in a (drug) name?
It’s been a few weeks since FiercePharmaMarketing‘s 2015 Drug Name Tournament came to a close. Now they’ve interviewed the winner, BioMarin’s Vimizin and asked where the name came from and what made it so successful.
Biotechnology firms are a growing sector of the pharma industry. As of January 2015, Forbes compiled a list of the United States’ ten biggest biotech companies according to their market value.
Analytical chemists play a critical role in many industries, and those with interdisciplinary backgrounds are in even greater demand. The demand is so great that some worry whether there will be enough analytical chemists to keep up with each industry’s growing needs.
Detailed in this article are the first 5 experiments featured in GEN’s list of recent studies carried out in space for for the purpose of human health or drug R&D. This is just a glimpse of the variety of life sciences research carried out in space in recent years…
BIO International Convention 2015: Résumé Builder Workshop
We are honored that the 2015 BIO International Convention will be hosted in Philadelphia this year from June 15-18th! Ashton Tweed’s Jordan Warshafsky, who served on the Program Committee to help create a top-quality educational program, will be presenting this workshop with Joulé Staffing Solutions. Save the date: June 18, 2015 at 2:00 & 3:00PM!
While nanomedicine is on the small side, it promises to be big business. Estimates suggest the market could grow to $130.9 billion by next year. One of the most recent developments are targeted nanomedicines, which specifically target cancer cells and HIV for example, but leave healthy cells intact.
Stay at the bench, or make way for the next generation? The NIH has noted a decline in the proportion of grants going to younger researches, and a rise in those going to researchers 66 and over. This raises the concern that the availability of grants and jobs for young scientists is limited.
